Published in Am Rev Respir Dis on May 01, 1982
Role of free radicals in the pathogenesis of cystic fibrosis. Thorax (1994) 1.08
The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion. J Clin Invest (1990) 0.86
Aberrant phagocyte function in Shwachman syndrome. Clin Exp Immunol (1987) 0.85
The inhibition of superoxide production by the soluble phase of cystic fibrosis sputum. Open Respir Med J (2008) 0.75
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med (2000) 5.82
Ragweed immunotherapy in adult asthma. N Engl J Med (1996) 4.69
Hyaline membrane disease. Am Rev Respir Dis (1975) 3.20
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med (1998) 3.05
Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med (1998) 2.96
Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol (2001) 2.59
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol (2000) 2.51
Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee. Am J Clin Nutr (1992) 2.36
The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med (1990) 2.35
Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med (2000) 2.29
Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol (1998) 2.22
Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels. Pediatrics (1990) 2.19
Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med (2000) 2.18
Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest (1989) 1.97
A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest (1994) 1.83
Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis. N Engl J Med (2000) 1.78
Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med (1997) 1.72
Association of rhinovirus infections with asthma. Clin Microbiol Rev (1999) 1.70
Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention. Am J Clin Nutr (1991) 1.66
Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol (1992) 1.63
Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy (2006) 1.62
Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process. Pediatrics (2001) 1.58
Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr (1998) 1.57
Evolution of dry powder inhaler design, formulation, and performance. Respir Med (2002) 1.55
Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness. Chest (1999) 1.51
Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res (1990) 1.51
Parents' knowledge of neonatal screening and response to false-positive cystic fibrosis testing. J Dev Behav Pediatr (1992) 1.47
Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol (1996) 1.37
Plasma tocopherol levels and tocopherol-lipid relationships in a normal population of children as compared to healthy adults. Am J Clin Nutr (1978) 1.36
Hypothesis: decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma. Ann Allergy Asthma Immunol (1998) 1.33
The correlation between asthma control and health status: the GOAL study. Eur Respir J (2006) 1.33
Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma. Am Rev Respir Dis (1992) 1.33
Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol (2001) 1.32
Peanut oil is not allergenic to peanut-sensitive individuals. J Allergy Clin Immunol (1981) 1.32
Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling. Pediatrics (1998) 1.32
Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med (1998) 1.30
Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol (1997) 1.29
Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am Rev Respir Dis (1975) 1.28
Histamine inhibition of neutrophil lysosomal enzyme release: an H2 histamine receptor response. Science (1976) 1.27
In vivo and in vitro studies on the use of the guinea pig as a model for virus-provoked airway hyperreactivity. Am Rev Respir Dis (1985) 1.27
The occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis. J Clin Invest (1977) 1.25
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia. Am J Dis Child (1984) 1.24
The magnitude and challenge of false-positive newborn screening test results. Arch Pediatr Adolesc Med (2000) 1.23
Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods. Pediatrics (1997) 1.22
Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis. Am J Dis Child (1982) 1.22
NIH conference. Asthma. Ann Intern Med (1994) 1.22
Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study. Allergy (2008) 1.20
Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols. Am J Hum Genet (1993) 1.19
Response to corticosteroids in the hypereosinophilic syndrome. Association with increased serum IgE levels. Arch Intern Med (1978) 1.18
Epidemiology of hyaline membrane disease in the United States: analysis of national mortality statistics. Pediatrics (1976) 1.18
Early life origins of asthma. J Clin Invest (1999) 1.17
Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group. J Allergy Clin Immunol (2000) 1.17
Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis (1991) 1.17
Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol (2000) 1.15
Analysis of United States neonatal mortality statistics from 1968 to 1974, with specific reference to changing trends in major causalities. Am J Obstet Gynecol (1977) 1.15
Parainfluenza virus-induced persistence of airway inflammation, fibrosis, and dysfunction associated with TGF-beta 1 expression in brown Norway rats. Am J Respir Crit Care Med (1996) 1.15
The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol (2000) 1.14
A case report and literature review of "primary" pulmonary histiocytosis X of childhood. Med Pediatr Oncol (1986) 1.14
A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma. Clin Res (1989) 1.14
Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med (1995) 1.14
Wisconsin cystic fibrosis chest radiograph scoring system. Pediatrics (1993) 1.14
Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. Roles of CD18 and intercellular adhesion molecule-1. J Immunol (1996) 1.13
Cytokine profiles of stimulated blood lymphocytes in asthmatic and healthy adolescents across the school year. J Interferon Cytokine Res (1997) 1.12
Wisconsin cystic fibrosis chest radiograph scoring system: validation and standardization for application to longitudinal studies. Pediatr Pulmonol (2000) 1.12
Decreased granulocyte response to isoproterenol in asthma during upper respiratory infections. Am Rev Respir Dis (1977) 1.12
The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. Am J Respir Crit Care Med (1997) 1.11
The role of leukotriene modifiers in the treatment of asthma. Am J Respir Crit Care Med (1998) 1.11
The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am J Respir Crit Care Med (1997) 1.11
The incidence of cystic fibrosis. Stat Med (1996) 1.11
Induction of choline phosphotransferase and lecithin synthesis in the fetal lung by corticosteroids. Science (1973) 1.10
The role of viral infections in the natural history of asthma. J Allergy Clin Immunol (2000) 1.09
Mechanisms of persistent airway inflammation in asthma. A role for T cells and T-cell products. Am J Respir Crit Care Med (1995) 1.09
Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis (1991) 1.08
IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis (1993) 1.08
Human airway and peripheral blood eosinophils enhance Th1 and Th2 cytokine secretion. Allergy (2006) 1.07
Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. J Immunol (1996) 1.07
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol (2000) 1.06
Cystic fibrosis newborn screening: impact of early screening results on parenting stress. Pediatr Nurs (1997) 1.06
Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test. Pediatr Pulmonol (1989) 1.06
Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J Immunol (1998) 1.05
Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis. J Clin Microbiol (2005) 1.04
Analysis of causes of neonatal death in the United States with specific emphasis on fatal hyaline membrane disease. Pediatrics (1982) 1.04
Discordance between male and female deaths due to the respiratory distress syndrome. Pediatrics (1986) 1.04
Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J Immunol (1995) 1.04
Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol (1998) 1.04
Parainfluenza 3 infection blocks the ability of a beta adrenergic receptor agonist to inhibit antigen-induced contraction of guinea pig isolated airway smooth muscle. J Clin Invest (1981) 1.03
Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis (1992) 1.03
Asthma. JAMA (1997) 1.02
Fatty acid abnormalities in cystic fibrosis. Pediatr Res (1985) 1.01
Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J Allergy Clin Immunol (1988) 1.01
Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening. Pediatrics (2000) 1.00
Impairment of isoproterenol, H2 histamine, and prostaglandin E1 response of human granulocytes after incubation in vitro with live influenza vaccines. Am Rev Respir Dis (1979) 1.00
Soybean oil is not allergenic to soybean-sensitive individuals. J Allergy Clin Immunol (1985) 1.00
Comparison of growth status of patients with cystic fibrosis between the United States and Canada. Am J Clin Nutr (1999) 1.00
Effect of isolation protocol on eosinophil function: Percoll gradients versus immunomagnetic beads. J Immunol Methods (1996) 0.99
A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis. J Pediatr (1979) 0.98